PPMD Community

Featured Blog Posts (384)


Staff
PPMD Designates UC Davis a Certified Duchenne Care Center

Today Parent Project Muscular Dystrophy (PPMD) named UC Davis Department of Physical Medicine and Rehabilitation Neuromuscular Disease Clinic (UC…

Continue

Added by PPMD on April 6, 2017 at 12:30pm — No Comments


Staff
PPMD Working with FDA to Plan Landmark Pediatric Advisory Committee Meeting to Improve Clinical Trial Experience

Later this spring – likely on or about May 18 – FDA’s Pediatric Advisory Committee will convene to consider the issue of allowing in-dwelling ports in Sarepta’s Essence trial.

Once again, our community is at a pivotal moment in our history where we…

Continue

Added by Annie Kennedy on April 5, 2017 at 10:00am — No Comments


Staff
PPMD's Duchenne Drug Development Roundtable Meeting Series, Part 3: Clinical Trial Readiness from the Viewpoint of Clinicians and Infrastructure

Accelerating trials. Protecting our robust therapeutic pipeline. Ensure as many hits on goal as we can.



Priorities shared by all of us.

And to achieve this, PPMD has convened our industry partners through our Duchenne Drug Development Roundtable…

Continue

Added by Annie Kennedy on April 5, 2017 at 11:00am — No Comments


Staff
ACTION ALERT: Make Your Voice Heard on New Healthcare Proposal

“Who’s on first?”

Remember that classic Abbott & Costello routine? Well, trying to track the quickly-shifting healthcare bill has felt much like watching that routine. Complex, confusing, and exhausting. But the stakes here are no laughing matter.

 

We…

Continue

Added by Annie Kennedy on March 21, 2017 at 10:00am — No Comments


Staff
PPMD's Duchenne Drug Development Roundtable Meeting Series, Part 2: Optimizing Clinical Trials

This week, PPMD convened Duchenne industry partners, experts in adaptive trial design and biostatistics, and innovative partners from outside of the Duchenne world who’ve revolutionized their clinical trial spaces for the second meeting of our Duchenne Drug Development Roundtable's 3-part meeting series, focusing on Clinical…

Continue

Added by Abby Bronson on March 3, 2017 at 10:00am — No Comments


Staff
PPMD Designates Ann & Robert H. Lurie Children's Hospital of Chicago a Certified Duchenne Care Center

Today Parent Project Muscular Dystrophy (PPMD) named Ann & Robert H. Lurie Children’s…

Continue

Added by PPMD on February 16, 2017 at 12:00pm — No Comments


Staff
Marathon Pharmaceuticals Pauses Commercialization of EMFLAZA™ (deflazacort)



UPDATE: February 13, 2017, 5:10 PM -- An additional statement from Marathon has been added to the blog



-----
---------------

Today, Marathon…

Continue

Added by PPMD on February 13, 2017 at 4:00pm — No Comments


Staff
Deflazacort Approved in the U.S. for Duchenne

UPDATE 2/10: Marathon has released links to new resources, including the EMFLAZA website (https://emflaza.com) and a Patient Support FAQ document (…

Continue

Added by Pat Furlong on February 9, 2017 at 5:00pm — 2 Comments


Staff
PPMD to Host Forum on Access to Emerging Therapies on February 13th, 2017

Following decades of strategic advocacy, research investment, and biopharmaceutical development, the U.S. Duchenne community recently arrived in the post-approval space and is poised to receive additional novel therapies from a robust innovation pipeline.…

Continue

Added by PPMD on February 7, 2017 at 1:57pm — No Comments


Staff
PPMD Awards $600,000 Grant to NJIT & Talem for Next Phase of Upper Extremity Exoskeleton

Robotics.

 

Ensuring that the worlds of teens and adults with Duchenne 'grow bigger', as they grow older by expanding their reach – both literally and figuratively.

  

Combing your hair. Lifting a glass to your mouth. Washing your hands. Pressing elevator…

Continue

Added by PPMD on January 18, 2017 at 9:00am — 1 Comment


Staff
PPMD Awards Nationwide Children’s Hospital $2.2 Million Grant to Explore Gene Therapy in Duchenne

Today, PPMD announced a $2.2 million dollar grant to Dr. Jerry Mendell, Dr. Louise Rodino-Klapac (co-PI), and Nationwide Children’s Hospital.  Our purpose in awarding this grant is to open and accelerate the field of gene therapy – a strategy that seemed impossible as a potential…

Continue

Added by Pat Furlong on January 6, 2017 at 9:00am — No Comments


Staff
What You Need to Know about Duchenne & Viral Gastroenteritis (That Horrible Stomach Bug!)

Viral gastrointestinal (GI) viruses are no fun for anyone, but they are especially worrisome for a person living with Duchenne muscular dystrophy. GI viruses affect the GI track – the stomach and intestine (i.e., ‘gut’) – resulting in abdominal pain/discomfort, nausea, vomiting, intestinal…

Continue

Added by Kathi Kinnett on January 4, 2017 at 10:30am — No Comments


Staff
Your gift to CRISPR will be Matched!

We have so much momentum. Let’s seize this moment.





First of all, let me say THANK YOU! Your gift to PPMD on #GivingTuesday helped us surpass our goal, and we could not be more grateful. It is a wonderful way to kick off our holiday season—and we wanted to make sure you were among the…

Continue

Added by Pat Furlong on December 1, 2016 at 9:30am — 1 Comment


Staff
Duchenne Carrier Study at Nationwide Children’s Hospital

Frequently, I get calls from mothers/sisters/aunts of people living with Duchenne about issues related to being a carrier of Duchenne:



  • Should they have carrier…
Continue

Added by Kathi Kinnett on November 14, 2016 at 11:00am — 2 Comments


Staff
Deflazacort Access: Navigating Potential Changes to Your Prescription

In an effort to answer some of the questions that have arisen with the potential FDA approval of deflazacort in the U.S., PPMD has worked with both Masters and Marathon to put together the resource below, which we hope will provide clarity.…

Continue

Added by Kathi Kinnett on October 31, 2016 at 2:00pm — No Comments


Staff
PPMD Designates Center for Duchenne Muscular Dystrophy at UCLA, a Certified Duchenne Care Center

PPMD Awards Twelfth Clinic Certification as Part of Effort to Ensure People with Duchenne Receive Optimal Care

 

The Center for Duchenne Muscular Dystrophy at the…

Continue

Added by PPMD on October 26, 2016 at 3:02pm — No Comments


Staff
PPMD Demands Anthem Reconsider Coverage of Approved Drug

It is hard to imagine anything worse than receiving the diagnosis of Duchenne. The dates and odysseys that brought us into this community differ, but the fervor we share to slow and stop the progression of this disease as it marches through our children is unparalleled in any…

Continue

Added by Pat Furlong on October 14, 2016 at 12:02pm — No Comments


Staff
FDA Grants Accelerated Approval to First Drug for Duchenne Muscular Dystrophy

Today, my sons are dancing! Today we ALL celebrate the first FDA approval in Duchenne. Today the FDA approved Exondys 51 (aka eteplirsen) injection, specifically indicated for patients…

Continue

Added by Pat Furlong on September 19, 2016 at 1:30pm — 4 Comments


Staff
PPMD Awards $200,000 Grant to Joshua Selsby, PhD of Iowa State University

Quercetin /ˈkwɜːrstn/ is a flavonol found in many fruits, vegetables, leaves and grains. It can be used as an ingredient in supplements, beverages, or foods. Source:…

Continue

Added by Abby Bronson on September 8, 2016 at 9:43am — No Comments

Featured Monthly Archives

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

© 2017   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service